Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.

Pharmaceutical

Aytu BioScience

Josh Disbrow

Victoria Cordova

Ryan Selhorn

Mark Oki

Russ McMahen

Greg Pyszczymuka

Margaret Cabano

Suzane Kennedy

Jarrett Disbrow

The Research and Development Team at Aytu BioScience spearheads the innovation and development of new therapeutic products, focusing on addressing significant unmet medical needs. This team conducts cutting-edge research, formulates new treatments, and ensures the strategic advancement of Aytu's therapeutic development pipeline, fostering both organic growth and acquisition-based expansion within the pharmaceutical sector.

Research and Development Team

Management and Strategy

Sales And Marketing Team

Finance and Accounting

Research and Development Team

About

Team members

Other teams at Aytu BioScience

Management and Strategy

Sales And Marketing Team

Finance and Accounting